These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 23839341)

  • 1. Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.
    Wang Y; Wu Y; Chen J; Zhao S; Li H
    Cardiology; 2013; 126(1):1-11. PubMed ID: 23839341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression.
    Li R; Lu K; Wang Y; Chen M; Zhang F; Shen H; Yao D; Gong K; Zhang Z
    Biochem Biophys Res Commun; 2017 Mar; 485(1):69-75. PubMed ID: 28202417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts.
    Cáceres FT; Gaspari TA; Samuel CS; Pinar AA
    FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracts from Artemisia annua Alleviates Myocardial Remodeling through TGF-β1/Smad2/3 Pathway and NLRP3 Inflammasome.
    Ma Z; Bai Z; Li B; Zhang Y; Liu W
    Curr Mol Pharmacol; 2024; 17():e18761429304142. PubMed ID: 38934281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirfenidone and the inflammasome: getting to the heart of cardiac remodeling.
    Roche P; Czubryt MP
    Cardiology; 2013; 126(1):59-61. PubMed ID: 23867498
    [No Abstract]   [Full Text] [Related]  

  • 8. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Gan W; Ren J; Li T; Lv S; Li C; Liu Z; Yang M
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):1-10. PubMed ID: 28986310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1
    Zhou J; Tian G; Quan Y; Li J; Wang X; Wu W; Li M; Liu X
    Oxid Med Cell Longev; 2020; 2020():7956274. PubMed ID: 32566102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation.
    Ren Z; Yang K; Zhao M; Liu W; Zhang X; Chi J; Shi Z; Zhang X; Fu Y; Liu Y; Yin X
    Can J Cardiol; 2020 Jun; 36(6):893-905. PubMed ID: 32224080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias.
    Nguyen DT; Ding C; Wilson E; Marcus GM; Olgin JE
    Heart Rhythm; 2010 Oct; 7(10):1438-45. PubMed ID: 20433946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β.
    Bracey NA; Beck PL; Muruve DA; Hirota SA; Guo J; Jabagi H; Wright JR; Macdonald JA; Lees-Miller JP; Roach D; Semeniuk LM; Duff HJ
    Exp Physiol; 2013 Feb; 98(2):462-72. PubMed ID: 22848083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis.
    Pan XC; Liu Y; Cen YY; Xiong YL; Li JM; Ding YY; Tong YF; Liu T; Chen XH; Zhang HG
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome.
    Liu W; Zhang X; Zhao M; Zhang X; Chi J; Liu Y; Lin F; Fu Y; Ma D; Yin X
    Cell Physiol Biochem; 2015; 35(6):2483-500. PubMed ID: 25967877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
    Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
    Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation.
    Hirano S; Higashimori A; Nagami Y; Nadatani Y; Tanigawa T; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Watanabe T; Fujiwara Y
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1096-1106. PubMed ID: 35434849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
    Wang Y; Gao B; Xiong S
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.
    Miric G; Dallemagne C; Endre Z; Margolin S; Taylor SM; Brown L
    Br J Pharmacol; 2001 Jul; 133(5):687-94. PubMed ID: 11429393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.
    Zhang CL; Zhao Q; Liang H; Qiao X; Wang JY; Wu D; Wu LL; Li L
    J Mol Cell Cardiol; 2018 Mar; 116():135-144. PubMed ID: 29438665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.